PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Oncotelic Therapeutics, Inc.
Filed: November 9, 2012
Period of Report: November 9, 2012
Accession Number: 0001193125-12-463538

View Document ↗ View on SEC.gov ↗